163 related articles for article (PubMed ID: 2438364)
1. Discriminant analysis in the clinical and biochemical diagnosis of primary liver cancer.
Farinati F; Varnier M; Piccoli A; Caldironi MW; Zotti S; Plebani M; Di Mario F; Naccarato R
J Med; 1986; 17(5-6):347-55. PubMed ID: 2438364
[TBL] [Abstract][Full Text] [Related]
2. Serum alpha-fetoprotein in chronic liver disease.
Weisz G; Udvardy M; Dalmi L; Kulcsár A
Acta Med Hung; 1983; 40(2-3):155-64. PubMed ID: 6199736
[TBL] [Abstract][Full Text] [Related]
3. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
Fujiyama S; Tsude K; Sakai M; Sato T
Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein, carcinoembryonic antigen and various biochemical tests in patients with tumorous and inflammatory liver diseases.
Weber P; Weberová D; Martínek K
Neoplasma; 1988; 35(5):605-13. PubMed ID: 2464143
[TBL] [Abstract][Full Text] [Related]
6. [Alkaline phosphatase isoenzymes and alpha-1-fetoprotein in hepatic neoplasms].
Di Blasi S; Cuffaro M; Rizzo S; Belvedere M; Genova G
Minerva Med; 1980 Apr; 71(14):1041-6. PubMed ID: 6154909
[TBL] [Abstract][Full Text] [Related]
7. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma].
Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541
[TBL] [Abstract][Full Text] [Related]
8. [Tumor antigens in the diagnosis of gastroenterological diseases (author's transl)].
Lehmann FG
Leber Magen Darm; 1975 Aug; 5(4):144-58. PubMed ID: 57561
[TBL] [Abstract][Full Text] [Related]
9. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
10. Discriminant analysis of biochemical parameters in liver disease.
Olubuyide IO; Festing MF; Chapman C; Higginson J; Whicher JT
Trop Gastroenterol; 1997; 18(1):15-9. PubMed ID: 9197166
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of alpha-fetoprotein assay as a tumor marker].
Endo Y; Iino S; Miyazaki J
Nihon Rinsho; 1990 Feb; 48 Suppl():949-52. PubMed ID: 1693988
[No Abstract] [Full Text] [Related]
12. [Discriminant function based on serum analyte for diagnosis of primary hepatic cancer].
Yi B; Luo JQ; Tang Y; Huang YD
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):373-5. PubMed ID: 12206007
[TBL] [Abstract][Full Text] [Related]
13. [Alpha 1 fetoprotein-determiantion in patients with liver diseases].
Lamerz R; Schmalhorst U; Grunst J
Z Gastroenterol Verh; 1976; (11):49-53. PubMed ID: 65863
[No Abstract] [Full Text] [Related]
14. [Diagnostic and prognostic importance of the alpha-fetoprotein test in liver cancer and cirrhosis].
Khazanov AI; Gerasimov GM
Klin Med (Mosk); 1986 Apr; 64(4):80-5. PubMed ID: 2425125
[No Abstract] [Full Text] [Related]
15. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum ferritin determination for hepatocellular carcinoma.
Nakano S; Kumada T; Sugiyama K; Watahiki H; Takeda I
Am J Gastroenterol; 1984 Aug; 79(8):623-7. PubMed ID: 6205585
[TBL] [Abstract][Full Text] [Related]
17. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Lamerz R; Runge M; Stieber P; Meissner E
Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
[TBL] [Abstract][Full Text] [Related]
18. [Value of alpha 1-fetoprotein (AFP) determination with an ultramicro-ELISA immunoassay in chronic liver diseases with special reference to hepatocellular cancer].
Reinhardt M; Schulze M; Machnik G; Jorke D; Laske V; Krombholz B; Kappauf G; Schröder S
Dtsch Z Verdau Stoffwechselkr; 1987; 47(5):230-41. PubMed ID: 2449324
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
20. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
